FARMINGTON HILLS, MICH. (September 10, 2015)— Beringea, a private equity firm providing growth capital to market-leading businesses, is pleased to announce a follow-on investment in Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology. The company has secured an unprecedented Series C funding round of $39.5 million, the single largest amount ever raised for a […]
ProNAi Therapeutics Inc . has collected $59.5 million after clinical studies showed that its lead drug could help non-Hodgkin’s lymphoma patients who are running out of options.
Between its two funds, Hopen manages more than $65 million, which it prefers to invest in the region.
Fund II is second life science fund managed by West Michigan-based Hopen Life Science Ventures Grand Rapids, Mich.– Hopen Life Science Ventures, a Grand Rapids-based life science venture capital fund, announced an initial close of $25 million for its second fund, Hopen Life Science Fund II. The fund will remain open to new limited partners […]